购物车
- 全部删除
- 您的购物车当前为空
BH3I-1 (BHI1) 是一种Bcl-2家族拮抗剂,作用于p53/mDM2,Kd 为 5.3 μM。它抑制BakBH3 肽与Bcl-xL 结合,Ki 为 2.6 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
BH3I-1 (BHI1) 是一种Bcl-2家族拮抗剂,作用于p53/mDM2,Kd 为 5.3 μM。它抑制BakBH3 肽与Bcl-xL 结合,Ki 为 2.6 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 233 | 现货 | |
2 mg | ¥ 329 | 现货 | |
5 mg | ¥ 538 | 现货 | |
10 mg | ¥ 872 | 现货 | |
25 mg | ¥ 1,620 | 现货 | |
50 mg | ¥ 2,660 | 现货 | |
100 mg | ¥ 4,320 | 现货 |
产品描述 | BH3I-1 (BHI1) is a Bcl-2 antagonist. |
靶点活性 | BH3-BCL XL:2.4 μM(Ki), MDM2-p53:5.3 μM(Kd) |
体外活性 | BH3I-1在体外抑制Bcl-xL异源二聚化,并诱导细胞色素c释放[1]。同时,BH3I-1在抑制其已报告的靶点Bcl-2/Bim与Bcl-xL/Bim的同时,还显著抑制p53/hDM2和p300/Hif-1α相互作用[2]。 |
细胞实验 | Cells (5×104 cells per well) are seeded into white 96-well plates (Costar) and treated with various concentrations of the compounds for 48 h. For zVAD-FMK protection experiments, cells are preincubated with 100 μM zVAD-FMK for 1 h before the addition of chemicals. Cell viability is determined with an MTS assay. For PI staining experiments, cells are grown in 24-well plates and then incubated with 2 μg ml/L PI. Cell death is determined by FACS analysis.(Only for Reference) |
别名 | BHI1 |
分子量 | 400.31 |
分子式 | C15H14BrNO3S2 |
CAS No. | 300817-68-9 |
Smiles | CC(C)C(N1C(=S)S\C(=C\c2ccc(Br)cc2)C1=O)C(O)=O |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: 60 mg/mL (149.9 mM) Ethanol: 11 mg/mL (27.5 mM) | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容